Article

Aziz Nazha on Adverse Events Associated With Treatment for MDS

Author(s):

Aziz Nazha

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).

Related Videos
Dr. Kevin Kalinsky Covers Targeted Therapy in HER2– Breast Cancer
Dr. Kevin Kalinsky Covers Targeted Therapy in HER2– Breast Cancer
Dr. Alan Tan is a genitourinary oncology (GU) and melanoma specialist at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee; an associate professor of medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center; and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
ctDNA Testing May Offer Patients With RCC ‘Peace of Mind’
Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.
Xtandi and Talzenna Therapy Shows Responses in Advanced Prostate Cancer
Discussing the Mission of CURE With Our Former and New Editors-In-Chief
Discussing the Mission of CURE With Our Former and New Editors-In-Chief
Image of woman with blonde hair.
Targeted Axillary Dissection Offers a Precise Option in Breast Cancer
Image of woman with blonde hair.
Guiding Patients Through Shared Decision-Making in Breast Cancer Care
Image of woman with brown hair.
Understanding the Best Practices Associated With CDK4/6 Therapy in Breast Cancer
Image of woman.
A Patient’s Journey With Colon Cancer and Her Advocacy Mission
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Colostomies and Colon Cancer, a Lifesaving Choice, Not a Last Resort
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Better Understanding Genetic Mutations Influence in Cancer Care
Related Content
Illustration of woman with blonde hair.
March 6th 2025

Looking For The Light After MDS

Jane Biehl Ph.D.
As a cancer survivor, I talk about where to look for the light when in utter darkness.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Image of Dr. Fakih.
February 27th 2025

ctDNA Alone ‘Not Sufficient’ When Monitoring Patients With Colorectal Cancer

Dr. Marwan Fakih
The addition of ctDNA testing to radiographic surveillance resulted in curative surgical intervention for 1.6% of patients with colorectal cancer.
Image of doctor with brown hair.
February 25th 2025

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

Dr. Vaia Florou
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Illustration of woman with blonde hair.
February 21st 2025

Cancer is Hard Enough Without Infections

Jane Biehl Ph.D.
As a cancer survivor, I describe battling both cancer and infections and the toll it takes on my body.
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 21st 2025

How Patients With Cancer Can Avoid Counterfeit Therapeutics Online

Dr. Megan Menon
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.